• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

January 1, 2012
Glen Spielmans, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Glen Spielmans, PhD Associate professor of psychology, Metropolitan State University, St. Paul, MN Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Subject:
GENETICS

Short Description:
Genes Plus Environment in Psychiatry: View Positive Studies Skeptically

Background:

Common sense dictates that genetic predispositions probably interact with life stressors to influence our mental health. Plenty of research has been published to evaluate whether this is actually true, but findings have been mixed. The first widely reported positive study, for instance, found that patients who had short alleles (versions) of the serotonin transporter gene (5-HTTLPR) were more likely to suffer depression in response to stressful life events than patients with normal alleles (Caspi A et al, Science 2003;301:386–389).

In response to this intriguing finding, a slew of studies tried to replicate this result. One meta-analysis of 14 direct replication studies found no significant link between 5-HTTLPR variation and depressive response to stressors (Risch N et al, JAMA 2009;301:2462–2471). But a later meta-analysis cast a wider net, including several indirect replications which used somewhat different measures of stress (such as hip fractures and heart disease) and depression—and it found a strong association between 5-HTTLPR variation, stress and depression (Karg K et al, Arch Gen Psychiatry 2011;68:444–454).

The latest study throws a monkey wrench into not only how 5-HTTLPR combines with stress but into all gene/ environment findings in psychiatry. Researchers examined results from all 103 published studies of gene/environment interactions in psychiatry published from 2000 to 2009. They found that while a whopping 96% of original gene/environment interaction studies were positive, only 27% of replication attempts were successful.

Replication studies with larger sample sizes were unlikely to find significant results, while positive replications usually had smaller sample sizes—implying that the most reliable replications are the most likely to cast the original findings into doubt (Duncan LE et al, Am J Psychiatry 2011;168:1041–1049).

TCPR's Take:
Dependable findings of gene/environment associations could eventually be helpful in both diagnosis and treatment—but we must await consistent positive replications before jumping on board.
General Psychiatry
KEYWORDS depressive_disorder genetics_and_psychiatry
Ccpr octnovdec2020 qa1 headshot spielmans 150x150
Glen Spielmans, PhD

Two New Meta-Analyses Compare Antidepressants

More from this author
www.thecarlatreport.com
Issue Date: January 1, 2012
SUBSCRIBE NOW
Table Of Contents
Deplin: Is it Just Folate by Another Name?
Nuedexta for Pseudobulbar Affect
Complementary and Alternative Medicine for Mood Disorders
Genes Plus Environment in Psychiatry: View Positive Studies Skeptically
Can Instant Messaging Enhance Treatment Outcomes?
DOWNLOAD NOW
Featured Book
  • MFB6eCover.jpg

    Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

    Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.